Actively Recruiting
Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Led by Institute of Oncology Ljubljana · Updated on 2024-10-18
200
Participants Needed
1
Research Sites
530 weeks
Total Duration
On this page
Sponsors
I
Institute of Oncology Ljubljana
Lead Sponsor
U
University of Ljubljana, Faculty of Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.
CONDITIONS
Official Title
Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Breast cancer patients with DCIS with an indication for adjuvant radiation therapy
You will not qualify if you...
- Any specific systemic oncological therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Oncology Ljubljana
Ljubljana, Slovenia, 1000
Actively Recruiting
Research Team
T
Tanja Marinko, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here